2015-10-20T14:22:05-05:00 2014-12-31 990 2014-01-01 237348742 The Transplantation Society % JEAN-PIERRE MONGEAU TRAN 5148741717 505 Rene-Levesque Boulevard SUITE Montreal Quebec CA H2Z 1Y7 JEAN-PIERRE MONGEAU EXECUTIVE DIRECTOR 2015-10-16 2014 2016-02-25 16:41:14Z X Jean-Pierre Mongeau 505 Rene-Levesque BLVD MONTREAL QUEBEC CA H2Z 1Y7 4684396 false X www.tts.org X 1972 DE INTERNATIONAL LEADERSHIP IN THE SCIENCE, EDUCATION, ETHICS AND PRACTICE OF TRANSPLANTATION 7 7 0 0 0 422484 907885 415634 1481259 324303 489754 0 0 1162421 2878898 398667 182319 0 0 739148 661531 0 0 0 1374162 1303394 2511977 2147244 -1349556 731654 8896667 9591413 340127 366420 8556540 9224993 The Transplantation Society provides the focus for global leadership IN TRANSPLANTATION FOR THE DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE, SCIENTIFIC COMMUNICATION, CONTINUING EDUCATION AND GUIDANCE ON THE ETHICAL PRACTICE. false false 223931 353034 Program and magazine publications including website development and WEBINARS AVAILABLE TO BOTH MEMBERS AND THE GENERAL PUBLIC. 182319 65702 Grants to section and regional societies for the purpose of travel, RESEARCH FELLOWSHIP AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. 672603 1125225 Events held in a variety of global venues where members of the COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. 1078853 true true false false false false false false false false true false false false false false true false false true true true true false false false false true true false false false false false false false false false false false false false false false false false false true 0 0 0 false true CA false false false false false false false false X 7 7 false false false false true true true true true false false true true true true false false true true false X JEAN-PIERRE MONGEAU 5148741717 505 Rene-Levesque BLVD STE 1401 MONTREAL QUEBEC CA H2Z 1Y7 Dr Francis Delmonico Immediate Past-President 1.0 0.0 X X 0 0 0 Dr Phillip O'Connell President 10.0 0.0 X X 0 0 0 Dr Marcelo Cantarovich Vice President 1.0 0.0 X X 0 0 0 Dr John Fung Senior Treasurer 1.0 0.0 X X 0 0 0 Dr Gabriel Danovitch Secretary 1.0 0.0 X X 0 0 0 Dr Nancy Ascher President-Elect 5.0 0.0 X X 0 0 0 Dr Elmi Muller Treasurer 1.0 0.0 X X 0 0 0 Jean-Pierre Mongeau Executive Director 40.0 0.0 X 95302 0 0 95302 0 0 0 false false false NONE 0 222690 685195 907885 Journals 511110 353034 353034 Global Alliance 511190 50000 50000 Meetings Registrations, Sponsorship 511190 991246 991246 Management Fees 561000 86979 86979 1481259 199538 199538 0 0 0 0 0 2095714 1805498 290216 290216 290216 0 0 0 0 2878898 1481259 489754 33858 33858 38450 38450 110011 110011 0 95302 95302 0 475756 204991 270765 0 37323 15913 21410 0 53150 19457 33693 0 183 183 5847 5847 0 0 43850 43850 27274 9610 17664 65885 1080 64805 99717 19194 80523 82099 82099 0 92295 46765 45530 224305 42512 181793 0 272777 272777 0 0 43975 38882 5093 14789 1422 13367 Journals 223931 223931 LOSS ON FOREIGN EXCHANGE 102317 102317 Foreign Taxes 4150 4150 2147244 1078853 1068391 0 1500681 1573517 134624 161023 0 0 683303 522411 0 0 0 0 101435 11569 0 0 145585 11160 237145 148010 86048 89135 6244991 7222598 0 0 0 0 0 0 0 0 8896667 9591413 273458 190952 0 0 66669 175468 0 0 0 0 0 0 0 0 0 0 0 0 340127 366420 X 6206137 8265177 2350403 959816 0 0 8556540 9224993 8896667 9591413 731654 -63201 X false true true false X 913939 3432633 1010347 422484 907885 6687288 379599 462870 1759669 415634 1481259 4499031 0 0 0 1293538 3895503 2770016 838118 2389144 11186319 0 0 0 0 0 11186319 205603 230942 227960 231754 199538 1095797 0 205603 230942 227960 231754 199538 1095797 0 0 1499141 4126445 2997976 1069872 2588682 12282116 0.91078 0.91816 0.08922 0.08184 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1987 1481 506 110306 82119 28187 124852 64410 60442 89135 2811548 -63201 1 -63200 2874748 4150 4150 2878898 2143094 2143094 4150 4150 2147244 PART XI, LINE 2D ROUNDING ADJUSTMENT 1 true East Asia and the Pacific Program Services Global Events 18180 Europe (including Iceland and Greenland) Grantmaking 88533 North America Grantmaking 1799 South America Grantmaking 1500 North America Investments 7222598 7332610 7332610 Europe (Including Iceland and Greenland) 5500 WIRE Europe (Including Iceland and Greenland) 30000 WIRE Research Awards East Asia and the Pacific 8 11950 WIRE Research Awards Europe (Including Iceland and Greenland) 12 17200 WIRE Research Awards North America 1 1200 WIRE Travel Grant East Asia and the Pacific 2 3730 WIRE Travel Grant North America 1 599 WIRE RECOGNITION AWARD East Asia and the Pacific 2 2500 WIRE RECOGNITION AWARD Europe (Including Iceland and Greenland) 2 3000 WIRE RECOGNITION AWARD South America 1 1500 WIRE false false false false false false Organization's Procedures for Monitoring Use of Grant Funds Outside the US The organization's process for monitoring the use of grant funds whether in the US or internationally starts with the selection criteria for each such award or grant: 1) Research Fellowships are only offered to a "Full" Member for a period of 2 years to support basic and clinical research in the field of transplantation in the laboratory or clinical unit. Full members shall be physicians, surgeons, scientists or other specialists, who are actively engaged in the science or clinical practice of organ, cell and tissue transplantation. Physicians and surgeons shall have advanced training or equivalent experience in the science and practice of organ and tissue transplantation. Non-physicians, including coordinators, statisticians, and policy makers who hold a doctoral degree, a Bachelors degree, or equivalent relevant certification must have professional experience in the field of transplantation with continuing and active involvement in clinical medicine or research, or transplantation public policy as determined by the Membership Committee. The process of limiting research fellowships only to full members allows the organization to ensure the recipients have the proper credentials to use the funds to further the organization's tax exempt purposes. The Fellowships are designed to provide research training for new young investigators with the potential of making a significant contribution to the field of transplantation. 2) Since the Medawar Prize and the recognition awards are only presented to recipients who make outstanding contributions in the field of transplantation, the selection criteria ensure that the investigator(s) receiving these grants are among the most influential in the field of organ transplantation as a result dictate that the funds be used in furtherance of the organization's mission. 3) Travel grants are presented to young investigators or those with financial difficulties who are members of organization. Priority is given to those young investigators under 40 years of age with the first authorship of an accepted abstract (especially those from developing countries). Again the requirement that the recipients be members of the organization and the selection criteria enable the organization to monitor that the funds will be used in accordance with its exempt purpose. true American Society of Transplantation 1120 Route 73 Suite 200 MtLaurel NJ 08054 421182936 15000 Coalition for Organ Failure Solutions 6203 Leeke Forest Court Bethesda MD 20817 204520402 8000 3 Dr. David Sachs Description of Organization's Procedures for Monitoring the Use of Grants The organization's process for monitoring the use of grant funds whether in theYUS or internationally starts with the selection criteria for each such award or grant: 1) Research Fellowships are only offered to a "Full" Member for a period of 2 years to support basic and clinical research in the field of transplantation in the laboratory or clinical unit. Full members shall be physicians, surgeons, scientists or other specialists, who are actively engaged in the science or clinical practice of organ, cell and tissue transplantation. Physicians and surgeons shall have advanced training or equivalent experience in the science and practice of organ and tissue transplantation. Non-physicians, including coordinators, statisticians, and policy makers who hold a doctoral degree, a Bachelors degree, or equivalent relevant certification must have professional experience in the field of transplantation with continuing and active involvement in clinical medicine or research, or transplantation public policy as determined by the Membership Committee. The process of limiting research fellowships only to full members allows the organization to ensure the recipients have the proper credentials to use the funds to further the organization's tax exempt purposes. The Fellowships are designed to provide research training for new young investigators with the potential of making a significant contribution to the field of transplantation. 2) Since the Medawar Prize and the recognition awards are only presented to recipients who make outstanding contributions in the field of transplantation, the selection criteria ensure that the investigator(s) receiving these grants are among the most influential in the field of organ transplantation and as a result dictate that the funds be used in furtherance of the organization's mission. 3) Travel grants are presented to young investigators or those with financial difficulties who are members of organization. Priority is given to those young investigators under 40 years of age with the first authorship of an accepted abstract (especially those from developing countries). Again the requirement that the recipients be members of the organization and the selection criteria enable the organization to monitor that the funds will be used in accordance with its exempt purpose. PART III - PROGRAM SERVICE ACCOMPLISHMENTS LINE 4A PROGRAM AND MAGAZINE PUBLICATIONS INCLUDING WEBSITE DEVELOPMENT AND WEBINARS AVAILABLE TO BOTH MEMBERS AND THE GENERAL PUBLIC - OVER 3,000 DISTRIBUTED DURING THE YEAR. LINE 4B AN INTERNATIONAL FORUM FOR THE WORLD-WIDE ADVANCEMENT OF ORGAN TRANSPLANTATION INCLUDING A FOCUS ON - DEVELOPMENT OF THE SCIENCE AND CLINICAL PRACTICE - SCIENTIFIC COMMUNICATION - CONTINUING EDUCATION - GUIDANCE ON THE ETHICAL PRACTICE OF TRANSPLANTATION. THE ORGANIZATION ACHIEVES THIS FOCUS BY MAKING GRANTS TO SECTION AND REGIONAL SOCIETIES FOR THE PURPOSE OF TRAVEL, RESEARCH FELLOWSHIP, AND RECOGNIZING INDIVIDUALS WHO HAVE MADE OUTSTANDING CONTRIBUTIONS IN TRANSPLANTATION. THE PRIMARY AWARDS AND GRANTS ARE: 1) THE MEDAWAR PRIZE, NAMED AFTER SOCIETY CO-FOUNDER SIR PETER MEDAWAR, IS RECOGNIZED AS THE WORLD'S HIGHEST DEDICATED AWARD FOR THE MOST OUTSTANDING CONTRIBUTIONS IN THE FIELD OF TRANSPLANTATION. THE MEDAWAR PRIZE HAS BEEN AWARDED TO TWO OR MORE RECIPIENTS AT EACH OF THE ORGANIZATION'S BIENNIAL CONGRESSES SINCE 1990. THE AWARD IS MADE POSSIBLE BY A CONTINUING GENEROUS GRANT FROM NOVARTIS PHARMA AG WHO AGREED THAT A PRESTIGIOUS PRIZE BE ESTABLISHED AND MAINTAINED TO RECOGNIZE THE OUTSTANDING INVESTIGATORS WHOSE CONTRIBUTIONS HAVE HAD SUCH A PROFOUND INFLUENCE ON THE FIELD OF ORGAN TRANSPLANTATION. THE MEDAWAR PRIZE IS UNIVERSALLY CONSIDERED TO BE COMMENSURATE WITH THE MOST OUTSTANDING WORLD PRIZES FOR SCIENTIFIC ACHIEVEMENT. 2) TTS RESEARCH FELLOWSHIPS ARE OFFERED FOR A PERIOD OF 2 YEARS TO SUPPORT BASIC AND CLINICAL RESEARCH IN THE FIELD OF TRANSPLANTATION IN THE LABORATORY OR CLINICAL UNIT OF A FULL TTS MEMBER. THE FELLOWSHIPS ARE DESIGNED TO PROVIDE RESEARCH TRAINING FOR NEW YOUNG INVESTIGATORS WITH THE POTENTIAL OF MAKING A SIGNIFICANT CONTRIBUTION TO THE FIELD OF TRANSPLANTATION. 3) TRAVEL GRANTS FOR YOUNG INVESTIGATORS AND FOR THOSE WITH FINANCIAL DIFFICULTIES WHO ARE MEMBERS OF THE ORGANIZATION. LINE 4C EVENTS HELD IN A VARIETY OF GLOBAL VENUES WHERE MEMBERS OF THE COMMUNITY ARE BROUGHT TOGETHER TO DISCUSS ADVANCEMENTS IN ORGAN TRANSPLANTATION. ORGAN TRANSPLANTATION IS A SUCCESSFUL THERAPY FOR END STAGE ORGAN FAILURE OF THE KIDNEY, LIVER, HEART, LUNG, PANCREAS AND INTESTINE. TRANSPLANTATION OF CELLS AND TISSUES ALSO TRANSFORMED THE THERAPEUTIC OPTIONS FOR PATIENTS WITH MALIGNANT HAEMATOLOGICAL DISEASE, EYE DISEASE AND ORTHOPAEDIC DISEASE, AND HAS THE POTENTIAL TO ALTER SIGNIFICANTLY THE THERAPEUTIC OPTIONS FOR PATIENTS WITH DIABETES AND A RANGE OF DISORDERS. THE ACCESS OF PATIENTS TO TRANSPLANTATION THERAPY VARIES WIDELY ACROSS THE GLOBE, PARTLY DETERMINED BY THE UNDERLYING LEVEL OF ECONOMIC DEVELOPMENT IN DIFFERENT STATES AND PARTLY DETERMINED BY OTHER FACTORS SUCH AS THE AVAILABILITY OF ORGAN, CELL AND TISSUE DONORS, OR THE SPECIALIZED PROVISION OF HEALTH SERVICES. THE ORGANIZATION HAS DETERMINED THAT IT WILL SEEK TO ADDRESS GLOBAL INEQUITIES IN TRANSPLANTATION THERAPY, IN ORDER TO FACILITATE APPROPRIATE ACCESS TO TRANSPLANTATION FOR ALL PATIENTS WHO WOULD BENEFIT. ORGANIZATION'S MEMBERS PART VI, LINE 6 - THE ORGANIZATION DOES NOT HAVE STOCKHOLDERS BUT DOES HAVE 5 CATEGORIES OF MEMBERS: 1) FULL MEMBERS WHICH MUST BE PHYSICIANS, SURGEONS, SCIENTISTS OR OTHER SPECIALISTS, WHO ARE ACTIVELY ENGAGED IN THE SCIENCE OR CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION. 2) TRAINEE MEMBERS SHALL INCLUDE INDIVIDUALS ENROLLED IN PRE OR POSTDOCTORAL TRAINING PROGRAMS RELEVANT TO THE SCIENCE AND CLINICAL PRACTICE OF ORGAN, CELL OR TISSUE TRANSPLANTATION, AND INDIVIDUALS WHO HAVE COMPLETED THEIR TRAINING BUT HAVE NOT YET QUALIFIED FOR FULL MEMBERSHIP. TRAINEE MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNCIL BUT MAY SERVE ON THE COMMITTEES. 3) EMERITUS MEMBERS SHALL BE FULL MEMBERS WHO HAVE ATTAINED THE AGE OF 65 OR HAVE RETIRED FROM PRACTICE IN THE FIELD OF TRANPLANTATION AND WHO FORMALLY REQUESTED EMERITUS MEMBERSHIP. EMERITUS MEMBERS MAY NOT VOTE OR HOLD OFFICE ON THE COUNCIL BUT MAY SERVE ON THE COMMITTEES AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. 4) ASSOCIATE MEMBERS SHALL INCLUDE INDIVIDUALS WHO HAVE DEMONSTRATED A SUSTAINED AND CONTINUED INTEREST IN THE FIELD OF TRANSPLANTATION BUT WHO DO NOT QUALIFY FOR FULL OR TRAINEE MEMBERSHIP. THESE INDIVIDUALS MAY NOT VOTE, HOLD OFFICE, OR SERVE ON COMMITTEES BUT WILL HAVE ALL OTHER SOCIETAL PRIVILEGES (I.E. PHARMACEUTICAL REPRESENTATIVES). 5) HONORARY MEMBERS SHALL BE INVITED TO BECOME HONORARY MEMBERS BY THE COUNCIL OF THE SOCIETY AND SHALL BE INDIVIDUALS WITH A DISTINGUISHED RECORD IN TRANSPLANTATION IRRESPECTIVE OF PROFESSIONAL DISCIPLINE. HONORARY MEMBERS SHALL NOT HAVE THE RIGHT TO VOTE OR HOLD OFFICE ON THE COUNCIL AND SHALL BE EXEMPT FROM PAYMENT OF ANNUAL MEMBERSHIP DUES. A PERSON MAY APPLY TO BECOME A MEMBER BY SUBMITTING A COMPLETED APPLICATION ALONG WITH THE NECESSARY DOCUMENTATION AND THE WRITTEN RECOMMENDATION OF TWO MEMBERS. THE COUNCIL BY A VOTE OF A MAJORITY OF ITS MEMBERS SHALL APPROVE AND ELECT THE MEMBERS. ELECTION OF GOVERNING BODY & DECISIONS OF GOVERNING BODY PART VI, QUESTION 7A - THE ORGANIZATION DOES HAVE MEMBERS WHO MAY ELECT MEMBERS OF THE GOVERNING BODY. IN ACCORDANCE WITH THE TERMS AND REQUIREMENTS OF ITS GOVERNING DOCUMENTS (I.E. BYLAWS), THE PRESIDENT, PRESIDENT-ELECT, AND PAST PRESIDENT SHALL SERVE FOR 2 YEARS; THE VICE PRESIDENT, THE SECRETARY, AND THE TREASURERS SHALL NORMALLY SERVE FOR 4 YEARS. THE FULL MEMBERS (AS DESCRIBED IN SCHEDULE O DESCRIPTION FOR PART VI, QUESTION 6)RECEIVE ELECTION BALLOTS TO ELECT THESE BOARD OF DIRECTOR POSITIONS. PART VI, QUESTION 7B - CERTAIN DECISIONS OF THE GOVERNING BODY ARE SUBJECT TO THE APPROVAL OF THE MEMBERS. IN ADDITION TO THE PRESIDENT, PRESIDENT-ELECT, PAST PRESIDENT, THE VICE PRESIDENT, THE SECRETARY, THE TREASURERS, AND THE DIRECTOR OF MEDICAL AFFAIRS, TWELVE COUNCILORS-AT-LARGE REPRESENTING NORTH AMERICA, LATIN AMERICA, EUROPE, ASIA, AFRICA/MIDDLE EAST, AND OCEANIA SHALL SERVE AS THE COUNCIL OF THE SOCIETY, THUS CONSISTING OF TWENTY PERSONS. ANY MAJOR DECISIONS OF THE ORGANIZATION MUST BE APPROVED BY MAJORITY VOTE BY THIS COUNCIL. THIS COUNCIL APPOINTS FULL MEMBERS TO SERVE ON STANDING OR SPECIAL COMMITTEES FROM TIME TO TIME TO DO SUCH THINGS AND HAVE SUCH POWERS AND SERVE UPON SUCH TERMS AS THE RESOLUTION ESTABLISHING THE COMMITTEE SHALL PROVIDE. ACTIONS OF ALL COMMITTEES SHALL BE SUBJECT TO REVIEW AND APPROVAL BY THE COUNCIL. PART VI, LINE 11B - REVIEW PROCESS FOR FORM 990 BEFORE THE FORM 990 IS FILED IT IS REVIEWED BY THE ORGANIZATION'S TREASURER AND THE PRESIDENT IN CONSULTATION WITH THE ORGANIZATION'S TAX ADVISORS, ERNST AND YOUNG, LLP. THE FINANCIAL REVIEW IS BASED ON THE ORGANIZATION'S COMPILED FINANCIAL STATEMENTS FOR THE RELEVANT TIME PERIOD. A COPY OF FORM 990 IS PROVIDED TO THE ORGANIZATION'S FULL BOARD OF DIRECTORS. PART VI, LINE 12C - CONFLICT OF INTEREST POLICY THE ORGANIZATION HIRES A THIRD PARTY PROVIDER TO REGULARLY AND CONSISTENTLY MONITOR AND ENFORCE THE CONFLICT OF INTEREST POLICY. UPON EMPLOYMENT AND ANNUALLY THEREAFTER EACH KEY EMPLOYEE AND OFFICER OF THE ORGANIZATION IS REQUIRED TO COMPLETE A CONFLICT OF INTEREST AND DISCLOSURE FORM, PROVIDING SUFFICIENT INFORMATION ABOUT HIS/HER PERSONAL INTERESTS AND RELATIONSHIPS SO THE THIRD PARTY PROVIDER CAN (1) DETERMINE WHETHER ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST MAY EXIST, AND (2) MONITOR WORK OR SERVICE ASSIGNMENTS TO AVOID PLACING THE KEY EMPLOYEE, OFFICER OR DIRECTOR IN A POSITION WHERE THERE MAY BE AN APPEARANCE, POTENTIAL OR ACTUAL, OF A CONFLICT OF INTEREST OR A QUESTION OF OBJECTIVITY. PART VI, LINE 15A - COMPENSATION APPROVAL PROCESS ON AN ANNUAL BASIS, THE BOARD OF DIRECTORS EVALUATES AND APPROVES THE CURRENT SALARY OF THE ORGANIZATION'S PRESIDENT AND OTHER OFFICERS. THIS EVALUATION PROCESS INCLUDES A REVIEW OF COMPARABLE DATA FOR THE POSITION OF DIRECTOR OF MEDICAL AFFAIRS FROM TAX EXEMPT ORGANIZATIONS IN THE MARKET WITH SIMILAR SIZE, DEMOGRAPHICS AND GEOGRAPHY. PART VI, LINE 19 - AVAILABILITY OF DOCUMENTS TO THE PUBLIC THE ORGANIZATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.